319 related articles for article (PubMed ID: 28281638)
21. MicroRNA-661 Enhances TRAIL or STS Induced Osteosarcoma Cell Apoptosis by Modulating the Expression of Cytochrome c1.
Fan L; Zhu C; Qiu R; Zan P; Zheng Z; Xu T; Li G
Cell Physiol Biochem; 2017; 41(5):1935-1946. PubMed ID: 28391262
[TBL] [Abstract][Full Text] [Related]
22. Overexpressing microRNA-34a overcomes ABCG2-mediated drug resistance to 5-FU in side population cells from colon cancer via suppressing DLL1.
Xie ZY; Wang FF; Xiao ZH; Liu SF; Tang SL; Lai YL
J Biochem; 2020 Jun; 167(6):557-564. PubMed ID: 32044957
[TBL] [Abstract][Full Text] [Related]
23. miR-1270 enhances the proliferation, migration, and invasion of osteosarcoma via targeting cingulin.
Liu Y; Guo W; Fang S; He B; Li X; Fan L
Eur J Histochem; 2021 Dec; 65(4):. PubMed ID: 34873899
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-497-5p Suppresses Tumor Cell Growth of Osteosarcoma by Targeting ADP Ribosylation Factor-Like Protein 2.
Sun Z; Li A; Yu Z; Li X; Guo X; Chen R
Cancer Biother Radiopharm; 2017 Dec; 32(10):371-378. PubMed ID: 29265919
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-140-5p regulates osteosarcoma chemoresistance by targeting HMGN5 and autophagy.
Meng Y; Gao R; Ma J; Zhao J; Xu E; Wang C; Zhou X
Sci Rep; 2017 Mar; 7(1):416. PubMed ID: 28341864
[TBL] [Abstract][Full Text] [Related]
26. LINC00460 promotes neuroblastoma tumorigenesis and cisplatin resistance by targeting miR-149-5p/DLL1 axis and activating Notch pathway in vitro and in vivo.
Xu Y; Qiu Z; Chen J; Huang L; Zhang J; Lin J
Drug Deliv Transl Res; 2024 Jul; 14(7):2003-2018. PubMed ID: 38161194
[TBL] [Abstract][Full Text] [Related]
27. miR-223/Hsp70/JNK/JUN/miR-223 feedback loop modulates the chemoresistance of osteosarcoma to cisplatin.
Tang Q; Yuan Q; Li H; Wang W; Xie G; Zhu K; Li D
Biochem Biophys Res Commun; 2018 Mar; 497(3):827-834. PubMed ID: 29432736
[TBL] [Abstract][Full Text] [Related]
28. miR-26b inhibits proliferation, migration, invasion and apoptosis induction via the downregulation of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 driven glycolysis in osteosarcoma cells.
Du JY; Wang LF; Wang Q; Yu LD
Oncol Rep; 2015 Apr; 33(4):1890-8. PubMed ID: 25672572
[TBL] [Abstract][Full Text] [Related]
29. MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma.
de Antonellis P; Medaglia C; Cusanelli E; Andolfo I; Liguori L; De Vita G; Carotenuto M; Bello A; Formiggini F; Galeone A; De Rosa G; Virgilio A; Scognamiglio I; Sciro M; Basso G; Schulte JH; Cinalli G; Iolascon A; Zollo M
PLoS One; 2011; 6(9):e24584. PubMed ID: 21931765
[TBL] [Abstract][Full Text] [Related]
30. miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1.
Xu Z; Wang T
Biochem Biophys Res Commun; 2014 Jun; 449(2):190-5. PubMed ID: 24802407
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-492 overexpression exerts suppressive effects on the progression of osteosarcoma by targeting PAK7.
Song X; Xie Y; Liu Y; Shao M; Yang W
Int J Mol Med; 2017 Sep; 40(3):891-897. PubMed ID: 28677719
[TBL] [Abstract][Full Text] [Related]
32. Potential Regulatory Effects of miR-182-3p in Osteosarcoma via Targeting EBF2.
Chen G; Yu W; Li Z; Wang Q; Yang Q; Du Z; Zhang G; Song Y
Biomed Res Int; 2019; 2019():4897905. PubMed ID: 30993113
[TBL] [Abstract][Full Text] [Related]
33. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
[TBL] [Abstract][Full Text] [Related]
34. LncRNA Sox2OT-V7 promotes doxorubicin-induced autophagy and chemoresistance in osteosarcoma via tumor-suppressive miR-142/miR-22.
Zhu K; Yuan Y; Wen J; Chen D; Zhu W; Ouyang Z; Wang W
Aging (Albany NY); 2020 Apr; 12(8):6644-6666. PubMed ID: 32302291
[TBL] [Abstract][Full Text] [Related]
35. Verification of microRNA expression in human endometrial adenocarcinoma.
Jurcevic S; Klinga-Levan K; Olsson B; Ejeskär K
BMC Cancer; 2016 Apr; 16():261. PubMed ID: 27039384
[TBL] [Abstract][Full Text] [Related]
36. LINC00467 facilitates osteosarcoma progression by sponging miR‑217 to regulate KPNA4 expression.
Yan J; Fang T; Zhang M; Zhou Q
Int J Mol Med; 2021 Mar; 47(3):. PubMed ID: 33537823
[TBL] [Abstract][Full Text] [Related]
37. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
38. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
Jiang Z; Jiang C; Fang J
Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
[TBL] [Abstract][Full Text] [Related]
39. The miR-15b-5p/PDK4 axis regulates osteosarcoma proliferation through modulation of the Warburg effect.
Weng Y; Shen Y; He Y; Pan X; Xu J; Jiang Y; Zhang Q; Wang S; Kong F; Zhao S; Zhou D; Zhang Y
Biochem Biophys Res Commun; 2018 Sep; 503(4):2749-2757. PubMed ID: 30093112
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1.
Zhang Y; Duan G; Feng S
Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
